These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 37621185)

  • 1. Exploring rat corpus cavernosum alterations induced by finasteride treatment and withdrawal.
    Diviccaro S; Herian M; Cioffi L; Audano M; Mitro N; Caruso D; Giatti S; Melcangi RC
    Andrology; 2024 Mar; 12(3):674-681. PubMed ID: 37621185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of oral finasteride on erectile function in a rat model.
    Zhang MG; Wu W; Zhang CM; Wang XJ; Gao PJ; Lu YL; Shen ZJ
    J Sex Med; 2012 May; 9(5):1328-36. PubMed ID: 22375859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroactive steroid levels and psychiatric and andrological features in post-finasteride patients.
    Melcangi RC; Santi D; Spezzano R; Grimoldi M; Tabacchi T; Fusco ML; Diviccaro S; Giatti S; Carrà G; Caruso D; Simoni M; Cavaletti G
    J Steroid Biochem Mol Biol; 2017 Jul; 171():229-235. PubMed ID: 28408350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of androgens on the expression of nitric oxide synthase mRNAs in rat corpus cavernosum.
    Park KH; Kim SW; Kim KD; Paick JS
    BJU Int; 1999 Feb; 83(3):327-33. PubMed ID: 10233504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydrotestosterone is the active androgen in the maintenance of nitric oxide-mediated penile erection in the rat.
    Lugg JA; Rajfer J; González-Cadavid NF
    Endocrinology; 1995 Apr; 136(4):1495-501. PubMed ID: 7534702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.
    Traish AM
    Adv Exp Med Biol; 2017; 1043():473-526. PubMed ID: 29224108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse side effects of 5α-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients.
    Traish AM; Hassani J; Guay AT; Zitzmann M; Hansen ML
    J Sex Med; 2011 Mar; 8(3):872-84. PubMed ID: 21176115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexual side effects of 5-α-reductase inhibitors finasteride and dutasteride: A comprehensive review.
    Fertig RM; Gamret AC; Darwin E; Gaudi S
    Dermatol Online J; 2017 Nov; 23(11):. PubMed ID: 29447628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer.
    Stanczyk FZ; Azen CG; Pike MC
    J Steroid Biochem Mol Biol; 2013 Nov; 138():10-6. PubMed ID: 23474436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An observational retrospective evaluation of 79 young men with long-term adverse effects after use of finasteride against androgenetic alopecia.
    Chiriacò G; Cauci S; Mazzon G; Trombetta C
    Andrology; 2016 Mar; 4(2):245-50. PubMed ID: 26763726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroactive steroid levels are modified in cerebrospinal fluid and plasma of post-finasteride patients showing persistent sexual side effects and anxious/depressive symptomatology.
    Melcangi RC; Caruso D; Abbiati F; Giatti S; Calabrese D; Piazza F; Cavaletti G
    J Sex Med; 2013 Oct; 10(10):2598-603. PubMed ID: 23890183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
    Bartsch G; Rittmaster RS; Klocker H
    Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of androgen on penile reflex, erectile response to electrical stimulation and penile NOS activity in the rat.
    Seo SI; Kim SW; Paick JS
    Asian J Androl; 1999 Dec; 1(4):169-74. PubMed ID: 11225889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety concerns regarding 5α reductase inhibitors for the treatment of androgenetic alopecia.
    Irwig MS
    Curr Opin Endocrinol Diabetes Obes; 2015 Jun; 22(3):248-53. PubMed ID: 25871957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis.
    Corona G; Tirabassi G; Santi D; Maseroli E; Gacci M; Dicuio M; Sforza A; Mannucci E; Maggi M
    Andrology; 2017 Jul; 5(4):671-678. PubMed ID: 28453908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse Sexual Effects of Treatment with Finasteride or Dutasteride for Male Androgenetic Alopecia: A Systematic Review and Meta-analysis.
    Lee S; Lee YB; Choe SJ; Lee WS
    Acta Derm Venereol; 2019 Jan; 99(1):12-17. PubMed ID: 30206635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research Brief: Self-Reports of a Constellation of Persistent Antiandrogenic, Estrogenic, Physical, and Psychological Effects of Finasteride Usage Among Men.
    Walf AA; Kaurejo S; Frye CA
    Am J Mens Health; 2018 Jul; 12(4):900-906. PubMed ID: 29318957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial Effects of Human Umbilical Cord Blood Mononuclear Cells on Persistent Erectile Dysfunction After Treatment of 5-Alpha Reductase Inhibitor in Rats.
    Oztekin CV; Yilmaz-Oral D; Kaya-Sezginer E; Kirlangic OF; Ozen FZ; Ozdal B; Topcu HO; Gur S
    J Sex Med; 2021 May; 18(5):889-899. PubMed ID: 33785264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CGP 53153: a new potent inhibitor of 5alpha-reductase.
    Häusler A; Allegrini PR; Biollaz M; Batzl C; Scheidegger E; Bhatnagar AS
    J Steroid Biochem Mol Biol; 1996 Feb; 57(3-4):187-95. PubMed ID: 8645628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MK-386, an inhibitor of 5alpha-reductase type 1, reduces dihydrotestosterone concentrations in serum and sebum without affecting dihydrotestosterone concentrations in semen.
    Schwartz JI; Tanaka WK; Wang DZ; Ebel DL; Geissler LA; Dallob A; Hafkin B; Gertz BJ
    J Clin Endocrinol Metab; 1997 May; 82(5):1373-7. PubMed ID: 9141518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.